INF2 mutations cause kidney disease through a gain-of-function mechanism
Science Advances · 2024
DOI: 10.1126/sciadv.adr1017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Balajikarthick Subramanian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Formins, Gain of Function Mutation, Podocytes, Glomerulosclerosis, Focal Segmental. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Heterozygosity for inverted formin-2 (INF2) mutations causes focal segmental glomerulosclerosis (FSGS) with or without Charcot-Marie-Tooth disease. A key question is whether the disease is caused by gain-of-function effects on INF2 or loss of function (haploinsufficiency). Despite established roles in multiple cellular processes, neither INF2 knockout mice nor mice with a disease-associated point mutation display an evident kidney or neurologic phenotype. Here, we compared responses to puromycin aminonucleoside (PAN)–induced kidney injury between INF2 R218Q and INF2 knockout mice. R218Q INF2 mice are susceptible to glomerular disease, in contrast to INF2 knockout mice. Colocalization, coimmunoprecipitation analyses, and cellular actin measurements showed that INF2 R218Q confers a gain-of-function effect on the actin cytoskeleton. RNA expression analysis showed that adhesion and mitochondria-related pathways were enriched in the PAN-treated R218Q mice. Both podocytes from INF2 R218Q mice and human kidney organoids with an INF2 mutation (S186P) recapitulate adhesion and mitochondrial phenotypes. Thus, gain-of-function mechanisms drive INF2-related FSGS and explain this disease’s autosomal dominant inheritance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
- Kidney Bioengineering Resource Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
- Department of Biochemistry, Geisel School of Medicine, Dartmouth College, Hanover, NH, USA.
- Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.
ORCID-Profile: Balajikarthick Subramanian, Sarah Williams, Sophie Karp, Miriam Lee, Cristian V Riella, Seth L Alper, Henry N Higgs, Martin R Pollak
Förderung
- NIDDK NIH HHS
Zitieren
APA
Subramanian, B., Williams, S., Karp, S., Hennino, M. F., Jacas, S., Lee, M., Riella, C. V., Alper, S. L., Higgs, H. N., & Pollak, M. R. (2024). INF2 mutations cause kidney disease through a gain-of-function mechanism. Science Advances. https://doi.org/10.1126/sciadv.adr1017
Vancouver
Subramanian B, Williams S, Karp S, Hennino MF, Jacas S, Lee M, et al. INF2 mutations cause kidney disease through a gain-of-function mechanism. Science Advances. 2024. doi:10.1126/sciadv.adr1017
BibTeX
@article{Subramanian2024,
author = {Subramanian, Balajikarthick and Williams, Sarah and Karp, Sophie and Hennino, Marie-Flore and Jacas, Sonako and Lee, Miriam and Riella, Cristian V and Alper, Seth L and Higgs, Henry N and Pollak, Martin R},
title = {INF2 mutations cause kidney disease through a gain-of-function mechanism},
journal = {Science Advances},
year = {2024},
doi = {10.1126/sciadv.adr1017}
}
EUVIMED